Skip to main content

Health condition · Clinically reviewed

Factor V Leiden, inherited clot risk, testing and safer choices.

The most common inherited thrombophilia in the UK. For most carriers it is a background risk to manage, not a diagnosis to fear.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Why trust this guide

  • 01

    Clinically reviewed

    Written by our editorial team and reviewed by a registered UK clinician before publication.

  • 02

    Sourced from guidance

    Checked against BSH, BJH and peer-reviewed thrombophilia sources you can see at the end.

  • 03

    Current for 2026

    Reflects modern UK guidance on inherited thrombophilia, DOACs, pregnancy care and hormonal risk.

Key facts

Factor V Leiden at a glance.

The essentials, in plain English. What the gene does, how common it is and what it means for clotting risk.

  • What it is

    An inherited change in the F5 gene (G1691A, Arg506Gln) that makes factor Va resistant to activated protein C, raising clot risk.

  • How common

    Around 5% of white Europeans carry one copy. Two copies (homozygous) is rare, roughly 1 in 1,000 to 1 in 5,000.

  • Clot risk

    Heterozygotes have a 3 to 8 times higher VTE risk. Homozygotes carry a 30 to 80 times higher risk.

  • Symptoms

    Most people never have a clot. Only about 10% of carriers develop venous thromboembolism (VTE) in their lifetime.

  • Testing

    Genetic PCR for F5 G1691A plus an activated protein C resistance (APCR) functional assay under specialist haematology.

  • Treatment

    No routine anticoagulation for well carriers. Situational prophylaxis and full anticoagulation after a VTE.

Why this guide matters

A gene, not a diagnosis of doom.

Most carriers live their whole lives without a clot. What matters is knowing your triggers and making a few sensible choices.

  • Testing is selective, not routine

    Screening the general population is not recommended. Testing is offered when the result will change management.

  • Hormones are the biggest lever

    Contraception and HRT choices matter more than almost anything else you can control day to day.

  • Pregnancy needs a plan

    Care is shared with maternal medicine. LMWH prophylaxis is tailored to your history, not a one-size template.

How the diagnosis is made

From history to a settled plan.

A structured approach, usually led by haematology, that starts with when a test is worth doing at all.

  1. 01

    Assessing

    Personal and family history

    Unprovoked VTE under 50, unusual-site thrombosis, recurrent clots or a strong family history point towards inherited thrombophilia.

  2. 02

    Assessing

    Decide who needs testing

    Testing is not routine. It is offered when the result will change management, usually after specialist review.

  3. 03

    Assessing

    Assess reproductive history

    Recurrent miscarriage, severe pre-eclampsia, IUGR, placental abruption or stillbirth may prompt selective testing.

  4. 04

    Confirming

    APCR functional assay

    A clotting-based screen for activated protein C resistance is often the first laboratory step.

  5. 05

    Confirming

    Genetic PCR for F5 G1691A

    Confirms Factor V Leiden and distinguishes heterozygous from homozygous carriers.

  6. 06

    Confirming

    Full thrombophilia screen

    Protein C and S, antithrombin, antiphospholipid antibodies, prothrombin G20210A, factor VIII and homocysteine as indicated.

  7. 07

    Family

    Cascade family testing

    First-degree relatives can be offered genetic counselling and testing where a change in management is likely.

Typical timeline: a first specialist visit to a settled plan in a few weeks.

Symptoms

What Factor V Leiden actually looks like.

The gene itself is silent. Anything you notice is a downstream clot, most often in the legs or lungs.

  • No symptoms at all

    Most carriers are diagnosed only after a clot in themselves or a relative. The gene alone does not cause symptoms.

  • Deep vein thrombosis (DVT)

    A swollen, tender, warm leg is the most common presentation. See our guide on blood clots for detail.

  • Pulmonary embolism (PE)

    Sudden breathlessness, pleuritic chest pain or collapse. A medical emergency at any age.

  • Unusual-site thrombosis

    Cerebral venous, hepatic, splanchnic or renal vein clots are less common but can occur.

  • Recurrent miscarriage

    A possible contributor, particularly to late miscarriage and placental problems. The evidence is mixed.

  • Hormone-related VTE

    Combined hormonal contraception and oral HRT raise clot risk further in carriers.

  • Post-surgical or travel VTE

    Immobility, surgery, plaster casts and long-haul travel can trigger a first clot in a carrier.

  • Red flag - suspected PE

    Sudden breathlessness or chest pain in a known carrier needs same-day assessment.

Treatment

How Factor V Leiden is managed in the UK.

For most carriers there is no drug to take every day. Anticoagulation is reserved for clots and higher-risk situations.

  • Watchful waiting

    Well carriers with no clot history usually need no anticoagulation. Advice focuses on avoiding avoidable triggers.

  • Situational LMWH prophylaxis

    Short courses of low molecular weight heparin around surgery, trauma, immobility or high-risk travel.

  • DOAC anticoagulation

    Apixaban or rivaroxaban for treatment of a confirmed VTE, in line with NICE and BSH guidance.

  • Warfarin

    A vitamin K antagonist used where DOACs are unsuitable, for example antiphospholipid syndrome or severe renal impairment.

  • Extended anticoagulation

    Considered for unprovoked, recurrent or life-threatening VTE, and often for homozygous carriers.

  • Contraception review

    Combined pill, patch and ring are avoided. Progestogen-only pill, implant or Mirena coil are usually preferred.

  • HRT counselling

    Transdermal HRT (patch or gel) is preferred over oral tablets because it carries a lower VTE risk.

  • Pregnancy planning

    Specialist maternal medicine input, with LMWH prophylaxis tailored to personal history and family risk.

What this guide is based on

The sources behind every claim on this page.

UK national guidance and specialist society standards, current at the time of last review.

Key references

Guidelines and standards we relied on.

A quiet reminder

This guide is for information, not medical advice.

Your GP or haematologist knows your history and can tell you which parts apply to you. If in doubt, get seen.

  • British Society for Haematology (BSH). Clinical guidelines for testing for heritable thrombophilia.

  • British Journal of Haematology (BJH). Guidance on the management of venous thromboembolism.

  • NICE. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158).

  • Royal College of Obstetricians and Gynaecologists (RCOG). Reducing the risk of venous thromboembolism during pregnancy (Green-top 37a).

Red flags

When Factor V Leiden needs urgent attention.

The gene itself is not an emergency. A clot is. These are the moments to act quickly and get help.

  • Suspected pulmonary embolism

    Sudden breathlessness, pleuritic chest pain, unexplained collapse or a very fast heart rate. Call 999 or attend A&E.

  • Painful swollen leg

    Unilateral calf or thigh swelling, tenderness and warmth needs same-day review to rule out DVT.

  • Neurological symptoms

    New severe headache, seizures, weakness or vision loss can signal cerebral venous thrombosis and needs urgent imaging.

  • Severe abdominal pain

    Unusual-site clots such as portal, hepatic or mesenteric vein thrombosis can present as sudden severe pain.

  • Pregnancy warning signs

    Leg swelling, breathlessness, severe headache, visual change or reduced fetal movements needs prompt obstetric review.

  • Bleeding on anticoagulation

    Heavy or unusual bleeding on a DOAC, warfarin or LMWH needs urgent clinical review and dose reconsideration.

  • Recurrent VTE despite treatment

    A further clot on anticoagulation is unusual and needs specialist haematology input.

  • Family cluster of young VTE

    Multiple relatives with early or unprovoked clots may warrant broader specialist assessment.

  • New oral contraceptive plan

    A known carrier considering combined hormonal contraception should be redirected to safer options before starting.

Living with it

A background risk, with a few clear rules.

Four everyday habits and choices make the biggest difference. Small, steady decisions that add up over years.

A quiet reminder

Awareness beats worry, every time.

Knowing you carry the gene lets you and your team plan around surgery, hormones, pregnancy and travel with confidence.

  1. 01 Everyday

    Move often, hydrate well

    Regular movement, hydration and avoiding long stretches of immobility all lower background clot risk.

  2. 02 Travel

    Plan long journeys

    On flights over four hours, use compression stockings, walk each hour and stay well hydrated. LMWH is selective and specialist-led.

  3. 03 Hormones

    Choose safer options

    Avoid the combined pill, patch and ring. Progestogen-only methods and transdermal HRT are usually preferred.

  4. 04 Family

    Talk to relatives

    A positive result can matter for parents, siblings and children. Cascade testing is offered through specialist genetics.

Frequently asked

Everything we get asked about Factor V Leiden.

Quick answers on risk, testing, contraception, HRT, pregnancy and family screening.

  • What is Factor V Leiden?

    Factor V Leiden is an inherited change in the F5 gene (the G1691A or Arg506Gln variant) that makes clotting factor Va harder for activated protein C to switch off. This tips the balance towards clotting and raises the risk of venous thromboembolism. It is the most common inherited thrombophilia in people of white European ancestry.

  • How much does it raise my risk of a clot?

    Carrying one copy (heterozygous) raises VTE risk about 3 to 8 times above baseline. Carrying two copies (homozygous) raises it 30 to 80 times. Even so, most heterozygous carriers never have a clot. Absolute risk depends on age, weight, hormones, pregnancy, surgery and family history.

  • Do I need blood thinners just because I carry the gene?

    No. Routine long-term anticoagulation is not recommended for asymptomatic carriers. The focus is on avoiding avoidable triggers and using situational prophylaxis around surgery, immobility, pregnancy or long-haul travel, guided by a haematologist.

  • Can I take the pill or HRT if I have Factor V Leiden?

    Combined hormonal contraception (pill, patch and ring) is generally avoided because it further raises VTE risk. Progestogen-only options, the implant and the Mirena coil are usually preferred. For HRT, transdermal patches or gels are preferred over oral tablets because they carry a lower clot risk.

  • What does it mean for pregnancy?

    Most pregnancies in Factor V Leiden carriers go well, but risks of VTE, pre-eclampsia and placental problems can be higher. Care is shared with a maternal medicine team who will individualise LMWH prophylaxis based on personal history, family history, homozygous or heterozygous status and other risk factors. Postnatal prophylaxis is often recommended.

  • Should my family be tested?

    Cascade testing is offered to first-degree relatives when a positive result would change management, for example around pregnancy, hormonal contraception or major surgery. It is arranged through specialist haematology or clinical genetics with counselling before and after testing.

Related content

Keep reading.

Pulse Healthcare concierge

Send us your enquiry

A concierge service for UK private healthcare. We match you with the best vetted clinics and consultants in our network - they then contact you directly.

So we can match you to the right clinician close to you.

We reply to every enquiry within 24 hours (Mon–Fri). Confidential - your details are never shared outside our vetted consultant network.